Page 163 - CW E-Magazine (27-8-2024)
P. 163

News from Abroad                                                              News from Abroad


 COLLABORATION  PRODUCT SAFETY CONCERNS
 Evonik using Knauer’s expertise to improve scale   Clean beauty activist urges US-FDA to ban toxic

 up of lipid nanoparticles formulations  hair relaxers


          An open letter from the Clean Beauty                            lungs or when coming into contact with
 Evonik is collaborating with Knauer   scientifi c instruments used in research
 Wissenschaftliche  Geräte  GmbH,  a   and commercial applications. Recently,   Action Network (CBAN) has urged US-  the eyes or skin.
       FDA Commissioner Robert Califf to act
 German  manufacturer  of  scientifi c  in-  Evonik   implemented   Knauer’s   on the agency’s promise to ban toxic hair   “The big picture here is that most
 struments, to improve the upscaling of   IJM NanoScaler Pro technology, which   relaxers amid research from the agency   consumers don’t know that the cos-
 lipid nanoparticle (LNP) formulations.  addresses the long-standing challenges   that  shows  some  hair  relaxers  contain   metics and beauty products we use
 in  nucleic  acid  LNP  formulations  by
 “By  combining  Evonik’s  formula-  reducing  the  need  for  labour-inten-  formaldehyde,  a  known  carcinogen.    don’t have to be verifi ed as safe. Peo-
 tion and scale-up expertise with Knauer’s   sive and time-consuming experiments,   CBAN  founder  Ms.  Daphne  Nguyen   ple  are  rightly  shocked  and  appalled
       said Mr. Califf must immediately prio-
                                                                          that  our  personal  care  products  con-
 technological  know-how,  customers   thereby signifi cantly reducing the time   ritise the USFDA rulemaking process on   tain formaldehyde, asbestos and other
 can  improve  effi ciency  and  increase   and  material  costs  associated  with   using formaldehyde in hair relaxers.  CBAN, a youth-led nonprofi t organi-  toxic chemicals and carcinogens,” Ms.
 speed  to  market,  signifi cantly  cutting   screening  for  optimal  LNP  formula-  sation aims to make  the cosmetics  Nguyen  said  in  her  letter.  CBAN’s
 the  initial  pre-clinical  development   tions on platforms that do not necessa-  The  letter  highlighted  the  delayed  industry  a  “safer,  greener  and  more  advocacy refl ects growing concern over
 time,” Evonik said in a press note.  worldwide  with  lipids  and  LNP  drug  rily upscale when introduced into more   rule-making process regarding the ban  ethical landscape” through scientifi c re-  the  underregulated  cosmetics  indus-
 product  development  activities.  The  proven IJM large scale systems.
 “Our extensive expertise in chemis-  LNP  market  alone  is  estimated  to  be   on  formaldehyde  in  hair  smoothing  search, public education and advocacy.  try and the urgent need for regulatory
                                                                          action to protect consumers from
 try and formulation science has enabled  over $600-mn (up to $1-bn) with conti-  Lipids  are  the  building  blocks  of   and  straightening  products.  Despite   Chemical hair relaxers break down  harmful  chemicals.  The  call  to  ban
       the  proposed  rule  being  listed  under
 us to capture a signifi cant proportion of  nued  growth  projected  over  the  next  living  cells  and  are  essential  for  the   Regulation  Identifi er  Number  (RIN)  proteins in the hair to straighten it. Ac-  formaldehyde aligns with the broader
 the growing market for mRNA and gene  decade.  effi cient encapsulation and delivery of   #0910-AI83  and  scheduled  for  public  cording to the USFDA, the formalde-  mission  to  promote  clean  beauty  and
 therapies.  Thanks  to  our  collaboration   mRNA  and  other  nucleic  acid-based   comment in April 2024, there has been  hyde used in these products presents  ensure  products  are  safe  for  both
 with  Knauer,  we  are  now  even  better   “Together with Knauer, we can in-  drugs.  The  nucleic  acids  are  encased   no progress.   health hazards when breathed into the  people and the planet.
 positioned to offer differentiation op-  crease the speed with which we go from  in an LNP composed of specifi c lipids,
 tions,” said Mr. Yann d’Hervé, head of  very small-scale prototypes to produc-  which not only protects the nucleic acid   LITHIUM MINING
 the Health Care business line at Evonik.  tion-scale  lead  formulations,  and  then  from degradation, but also ensures its
 directly  into  GMP  production  of  drug  safe delivery into cells where it can be   Pilbara Minerals set to acquire Latin Resources
 Nucleic acid therapeutics represent  products,” said Ms. Andrea Engel, head  released.  LNPs  have  emerged  as  the
 a huge and expanding proportion of the  of Growth Projects Evonik Health Care.  most  advanced  drug  delivery  system,   Australian  lithium  mining  fi rms  –   Minerals  shares  upon  implementing
 overall  parental  drugs  market.  Evon-  highlighted by their role in the global   Pilbara Minerals and Latin Resources –   the scheme. Based on Pilbara Minerals’
 ik  supplies  pharmaceutical  companies   Knauer  is  known  for  its  high-end  fi ght against COVID-19.  have announced plans to merge. Pilbara   closing  price  of  $2.85  per  share  on
                                                                          August 14, 2024, the transaction implies
       Minerals  has  inked  a  binding  scheme
 DKSH extends distribution deal with Cosucra in   implementation  agreement  (SIA)  to   a value of $0.20 per Latin share, repre-
 Australia and New Zealand  acquire  smaller  peer,  Latin  Resources     senting a 57% premium to the compa-
       for  an  implied  value  of  A$559.9-mn
                                                                          ny’s 10-day volume weighted average
       ($369.4-mn). As  part  of  the  proposed                           price  of  $0.127  per  share.    Latin
 DKSH  has  expanded  its  exclusive   for healthy, sustainable, and tasty food   transaction,  Pilbara  Minerals,  which   Resources’  board  has  unanimously
 distribution agreement with Cosucra, a   products. Cosucra’s naturally produced,   has a market capitalisation of $8.57-bn,   recommended  the  deal  in  the  absence
 Belgian producer of natural and healthy   trademarked ingredient range includes   will  secure  Latin  Resources’  fl agship   of a better proposal.
 food ingredients, in Australia and New   Fibrulose and  Fibruline chicory root   Salinas  Lithium  Project,  which  has
 Zealand.   fi bre, Pisane pea protein isolate range,   potential to become a top 10 hard rock   Pilbara  Minerals’  CEO  Mr.  Dale
 as well as Swelite pea fi bre, and Nastar   lithium  operation  by  production  glob-  Henderson  said  the  acquisition  is
 DKSH’s  performance  materials   pea starch.  ally. The project lies in the Minas Ge-  on-strategy,  diversifying  the  business
 business  unit  will  provide  business   rais region of Brazil, with development   with  what  is  believed  to  be  a  coun-
 development, marketing, sales, logistics,   Cosucra and DKSH have been part-  fl exibility to supply new markets.  ter-cyclical,  accretive  extension  that
 and distribution services for Cosucra’s   Cosucra  utilises  the  properties  of  nering  in  several  countries  in  Europe   shares in the new merged company for  builds  out  the  company’s  position  as
 range of dietary fi bres and plant-based  two  natural  raw  materials,  chicory  and Asia, including Germany, Switzer-  Under  the  binding  SIA,  Latin  Re-  each  Latin  Resources  share  held,  and  one  of  the  “leading  lithium  materials
 proteins in Australia and New Zealand.  roots and peas, to develop ingredients  land, and the Philippines.   sources shareholders will receive 0.07  will  also  own  about  6.4%  of  Pilbara  suppliers globally”.

 162  Chemical Weekly  August 27, 2024  Chemical Weekly  August 27, 2024                               163


                                      Contents    Index to Advertisers    Index to Products Advertised
   158   159   160   161   162   163   164   165   166   167   168